Biogen's MS drug in question
Jul 15, 2011 | Posted by: roboblogger | Full story: Investor's Business Daily
Twelve more cases of a rare brain infection occurred in multiple-sclerosis patients taking the biotech's drug Tysabri, which it sells with Elan , bringing the number of affected patients to 145.
Lets stop pushing poison. Docs wouldn't take it. F--- big drug companies. CCSVI, healthy diet and pt.
|Drugmaker Elan plans to explore sale of company (Jun '13)||Jun '13||HumanSpirit||1|
|Plavix deal stokes pharma stocks; Biogen, Elan ... (Apr '06)||May '13||Yadiel||5|
|IPO Preview: ChemoCentryx (May '12)||May '12||Robson||1|
|Neuroimaging Technique Supports Reduction in Am... (Mar '10)||Mar '10||sophia brown||1|
|Patients taking Tysabri report improvement in p... (Sep '09)||Sep '09||tysabri_ftl||1|
|''Step Inside MS'' National Tour Brings First-o... (Sep '07)||Sep '07||Michelle||3|